West Nile-Innovator+EWThis page contains information on West Nile-Innovator+EW for veterinary use.
The information provided typically includes the following:
- West Nile-Innovator+EW Indications
- Warnings and cautions for West Nile-Innovator+EW
- Direction and dosage information for West Nile-Innovator+EW
West Nile-Innovator+EWThis treatment applies to the following species:
Encephalomyelitis-West Nile Virus Vaccine
Eastern & Western, Killed Virus
For Veterinary Use Only
West Nile-Innovator+EW Indications
For vaccination of healthy horses as an aid in the prevention of viremia caused by West Nile virus, and as an aid in the prevention of equine encephalomyelitis due to Eastern and Western viruses. Efficacy of the West Nile fraction was demonstrated in horses that received two doses of the vaccine and were challenged one year post-vaccination with West Nile virus. The vaccine protected 95% of the vaccinates against infection, while 82% of the controls were viremic.
DOSE: Horses, inject one 1 mL dose intramuscularly using aseptic technique. Administer a second 1 mL dose 3 to 4 weeks after the first dose. A 1 mL booster dose should be given annually. Early revaccination may be advisable when horses are faced with an outbreak or with other conditions which might make heavy exposure likely.
West Nile-Innovator+EW Caution
Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. Use entire contents when first opened. In some instances, transient local reactions may occur at the injection site. Do not vaccinate within 21 days before slaughter. In case of anaphylactoid reaction, administer epinephrine.
Thimerosal, neomycin and polymyxin B added as preservatives.
Zoetis Inc., Kalamazoo, MI 49007
U.S. Vet. License No. 190
333 PORTAGE STREET, KALAMAZOO, MI, 49007
Copyright © 2022 Animalytix LLC. Updated: 2021-12-02